K202300 is an FDA 510(k) clearance for the Optellum Virtual Nodule Clinic, Optellum software, Optellum platform. This device is classified as a Computer-assisted Diagnostic Software For Lesions Suspicious For Cancer (Class II - Special Controls, product code POK).
Submitted by Optellum, Ltd. (Oxford, GB). The FDA issued a Cleared decision on March 5, 2021, 204 days after receiving the submission on August 13, 2020.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2060. Assist Users In Characterizing Lesions Identified On Acquired Medical Images.